Catiil, Armando, NONE. D.

HRN: 12-67-50  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2023
MUPIROCIN 2%, 15G (TUBE)
06/02/2023
06/09/2023
TOPICAL
Apply To Affected Area
Q8H
DM FOOT
Waiting Final Action 

Indication:  Empiric Then Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: